Synthetic peptides were first developed by researchers with the aim to address physiological disorders, including reducing obesity. Researchers speculate that these research peptides may contribute to the efficacy of several metabolic processes.
Peptides—What are they?
Proteins are made up of peptides, short chains of amino acids. Their short forms are considered to allow for speedy absorption in the circulation. Researchers speculate that peptides may be crucial in preserving certain metabolic processes.
The peptides outlined below all stand out from one another in unique ways. However, they have all been researched for their proposed potential to induce rapid weight loss.
The anterior pituitary gland appears to secrete increased growth hormone in response to most peptides. Inhibition of lipoprotein lipase is one of the most noticeable effects of growth hormone. Triglyceride and cholesterol levels may also be lowered.
Some peptides, such as Semaglutide and Tirzepatide, appear to mimic the effects of GLP-1. Findings imply that this mechanism of action may enable these peptides to reduce blood sugar levels and suppress appetite. This process may reduce the risk of obesity and type 2 diabetes.
However, 5-Amino-1 MQ appears to possess an entirely different mechanism of action. Investigations purport that the peptide may block an enzyme called nicotinamide N-methyltransferase (NNMT), potentially resulting in a higher metabolic rate.
Consequently, researchers speculate that these peptides may increase the abdomen and subcutaneous fat thermogenesis. Scientists hypothesize that they may also help prevent the potentially lethal condition of visceral obesity.
GLP-1 Semaglutide Peptide
Semaglutide is a GLP-1 receptor agonist, sometimes categorized alongside other peptides with alleged divergent mechanisms of action. Studies suggest an artificial incretin may act similarly to glucagon-like peptide-1 (GLP-1).
Semaglutide has been studied within the context of obesity in animal test models, to observe its impact in weight management. Semaglutide, researchers suggest, may simply be a means of keeping blood sugar levels stable. Glycemic management may be useful when losing or gaining weight rapidly (bulking). Research suggests that Semaglutide may stimulate the pancreas to secrete adequate insulin when the blood sugar is high. Therefore, it may aid insulin production.
AOD 9604 Peptide
The growth hormone (HGH) C-terminus fragment (AOD 9604), is a synthetic analog of this region (176-191). This hexadecapeptide has been suggested to affect fat metabolism by potentially increasing lipolysis and decreasing lipogenesis. Without affecting metabolism as a whole, findings imply that AOD 9604 may possibly increase fat breakdown in fat-rich locations.
The pentapeptide Ipamorelin (Aib-His-D-2-Nal-D-Phe-Lys-NH2) has been suggested by researchers to exhibit high GH-releasing potency, via efficacy studies conducted in vitro. As a synthetic analog of GHRP-1, it may act similarly to the natural hormone and potentially exhibit comparable impacts.
Findings suggest this peptide seems functionally superior to comparable peptides, such as GHRP-2 and GHRP-6. The key potential of Ipamorelin is considered its possible impact in increasing blood growth hormone levels. Elevated growth hormone (GH) levels in the blood are considered responsible for additional physical changes.
Studies suggest that Tesamorelin may operate on particular target areas because it appears to mimic the activity of an endogenous hormone. The specificity of Tesamorelin’s mode of action follows naturally, scientists speculate.
Research suggests Tesamorelin may interact with the anterior pituitary gland’s growth hormone-releasing receptors (GHRHr). The pituitary’s somatotrophic cells are considered then to activate to produce and release growth hormone (GH) in response to this binding.
Adipocytes (fat cells), hepatocytes (liver cells), myocytes (muscle cells), and osteoblasts (bone cells) appear to be the primary targets of growth hormone (GH).
Findings imply that serum growth hormone (GH) levels are kept from skyrocketing by activating a negative feedback mechanism in response to Tesamorelin-induced GH release. Investigations purport that asTesamorelin may possibly induce the pituitary gland to generate growth hormone (GH), it also may help keep the Hypothalamus and the endocrine system in sync.
Proposed Properties of Synthetic Peptides
Researchers often explore peptides in their studies within contexts other than muscle development and strengthening, such as speedy wound healing and joint repair. Findings imply that oxidative stress may be mitigated thanks to the antioxidant potential suspected to be present in most peptides. Investigations purport that peptides with possible anti-inflammatory properties may help reduce pain and swelling in addition to potentially boosting immunity.
Researchers can purchase such compounds from biotechpeptides.com specifically for laboratory testing and research use.
[i] Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999 Aug;12(2):139-57. doi: 10.2165/00063030-199912020-00007. PMID: 18031173.
[ii] Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4. doi: 10.1152/ajpendo.00201.2006. Epub 2006 Jul 5. PMID: 16822960.
[iii] Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
[iv] Forbes J, Krishnamurthy K. Biochemistry, Peptide. 2022 Aug 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32965931.
[v] Vélez EJ, Perelló-Amorós M, Lutfi E, Azizi S, Capilla E, Navarro I, Pérez-Sánchez J, Calduch-Giner JA, Blasco J, Fernández-Borràs J, Gutiérrez J. A long-term growth hormone treatment stimulates growth and lipolysis in gilthead sea bream juveniles. Comp Biochem Physiol A Mol Integr Physiol. 2019 Jun;232:67-78. doi: 10.1016/j.cbpa.2019.03.012. Epub 2019 Mar 15. PMID: 30885833.
[vi] Jeong S, Yoon S, Kim S, Jung J, Kor M, Shin K, Lim C, Han HS, Lee H, Park KY, Kim J, Chung HJ, Kim HJ. Anti-Wrinkle Benefits of Peptides Complex Stimulating Skin Basement Membrane Proteins Expression. Int J Mol Sci. 2019 Dec 20;21(1):73. doi: 10.3390/ijms21010073. PMID: 31861912; PMCID: PMC6981886.
[viii] Baruah MP, Kalra S. The novel use of GLP-1 analogue and insulin combination in type 2 diabetes mellitus. Recent Pat Endocr Metab Immune Drug Discov. 2012 May;6(2):129-35. doi: 10.2174/187221412800604563. PMID: 22435393.